Authors:
Avinash Singh, Amit Patil
Download free PDF
Pasteurizers and Sterilizers Market Size & Share 2026-2035
Report ID: GMI12647
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Pasteurizers and Sterilizers Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Pasteurizers and Sterilizers Market Size
The global pasteurizers and sterilizers market was valued at USD 9.20 billion in 2025, is expected to reach USD 9.70 billion in 2026, and is projected to grow at a 5.8% CAGR (2026–2035) to USD 16.20 billion in 2035.
Pasteurizers and Sterilizers Market Key Takeaways
Market Leader: STERIS plc led with over 9.7% market share in 2025.
Leading Players: Top 5 players in this market include STERIS plc, JBT Marel Corporation, Alfa Laval AB, GEA Group AG, Getinge AB, which collectively held a market share of 30.0% in 2025.
The market encompasses industrial pasteurization systems used to control microbial loads in food and beverage production and sterilization equipment designed for validated microbial elimination in pharmaceutical, healthcare, and food-processing environments.
The pasteurizers and sterilizers market is evolving from a volume-led equipment category into a more differentiated market shaped by regulatory validation, aseptic process requirements, and lifecycle operating economics. Food and beverage applications retain a broad installed base, while pharmaceutical, biologics, and medical-device customers increasingly favor systems that support traceability, qualification, and specialized material handling.
GMI Analyst View
Based on our market intelligence and primary research conducted with industry stakeholders, the pasteurizers and sterilizers market generated USD 8.00 billion in revenue in 2022, establishing the historic baseline from which the market has expanded steadily. This progression informs our forward-looking assessment of demand across food safety, pharmaceutical, and healthcare applications through the forecast period.
Pasteurizers and Sterilizers Market Trends, Growth Drivers & GMI Forecast Outlook
Regulatory enforcement, biologics capacity additions, and demand for shelf-stable foods are expanding the addressable equipment base, while capital intensity and validation burdens constrain replacement timing. The resulting outlook favors suppliers that can combine throughput performance with documented compliance, service capability, and lower lifecycle resource consumption.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Food safety requirements translate public-health priorities into recurring capital decisions for dairy, juice, packaged-food, and water-processing operators. As manufacturers add lines, renew site approvals, or enter export channels, validated thermal processing becomes a production prerequisite rather than a discretionary efficiency upgrade. This favors suppliers able to integrate hygienic design, automated controls, and documentation into complete processing systems.
Biologics and sterile injectable manufacturing create a distinct demand profile. These facilities require validated sterile conditions across component handling, aseptic processing, and fill-finish operations, making sterilization equipment integral to capital-program execution. Expansion by large drug manufacturers and contract development and manufacturing organizations broadens demand for high-specification systems, particularly where customers require formal qualification support and lifecycle service.
Shelf-stable food and beverage formats are also changing technology selection. Ambient distribution can lower cold-chain dependence, but it raises the importance of precise UHT treatment, aseptic design, and reliable continuous operation. Suppliers that can improve thermal efficiency without compromising product quality are positioned to benefit as processors modernize legacy infrastructure.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Capital intensity is most consequential for food and beverage processors operating with narrow margins and long replacement cycles. Large UHT lines, retort systems, and other high-capacity sterilization platforms must deliver measurable output, yield, or energy benefits before buyers can justify approval. Where financing options are limited, operators are more likely to extend the operating life of installed equipment and defer modernization.
Lifecycle costs compound this purchasing friction. Cleaning-in-place requirements protect hygiene performance, but they consume energy, water, cleaning agents, and productive line time. Technologies that reduce fouling or extend operating intervals can improve plant economics, yet the fundamental operating burden remains material for dairy, juice, and other high-throughput applications.
Validation complexity is a separate barrier in pharmaceuticals and medical devices. Sterile manufacturers must demonstrate that systems, loads, procedures, and monitoring practices consistently meet regulatory expectations. This documentation burden favors established technologies with recognized validation histories and can make transitions to alternative sterilization methods slower than their technical advantages alone would suggest.
GMI Analyst View
We see the market increasingly separating by procurement logic. Pharmaceutical and healthcare buyers prioritize qualification depth, risk mitigation, and long-term service continuity, whereas food processors place greater emphasis on throughput, energy use, and payback discipline. This split supports a more favorable demand mix for specialized sterilization systems, but it also leaves broader equipment renewal exposed to processing-margin pressure.
Pasteurizers and Sterilizers Market Segment Analysis
By Product Type
The pasteurizers and sterilizers market product mix is shifting toward higher-specification sterilization technologies as pharmaceutical and healthcare applications expand. Pasteurizers generated USD 3.86 billion in 2025 and are expected to account for 40.0% of the global market in 2035. Their demand remains anchored in dairy, juice, and packaged-food processing, where hygienic throughput and thermal efficiency are central purchasing criteria.
Sterilizers are projected to generate USD 9.72 billion in 2035 and advance at a 6.2% CAGR (2026–2035). Their stronger value contribution reflects demand from regulated sterile manufacturing, hospital central sterile supply departments, and medical-device applications that require validated process control and specialized technology configurations.
Pasteurizers
Plate pasteurizers generated USD 1.24 billion in 2025 and are projected to represent 30.0% of pasteurizer revenues in 2035. Their compact footprint, thermal-regeneration efficiency, and compatibility with cleaning-in-place regimes keep them central to continuous dairy and beverage operations, although their relative position is moderated by the growing need for ambient-shelf-life processing.
UHT pasteurizers are expected to generate USD 1.43 billion in 2035 and grow at a 7.4% CAGR (2026–2035). The format is increasingly important for ready-to-drink dairy, plant-based beverages, and other products that require aseptic processing and reduced dependence on refrigerated distribution.
Sterilizers
Thermal and heat sterilizers generated USD 2.56 billion in 2025 and are expected to account for 45.0% of sterilizer revenues in 2035. Steam autoclaves, dry-heat systems, and related platforms maintain a durable role because they have extensive validation histories and broad compatibility with pharmaceutical, hospital, and medical-device workflows.
Chemical and gas sterilizers are projected to generate USD 2.14 billion in 2035, following a 22.0% share of sterilizer revenues in 2025. The segment remains important for materials that cannot tolerate heat or moisture, while environmental and workplace-control requirements are supporting interest in alternative low-temperature chemistries.
Radiation sterilizers generated USD 0.96 billion in 2025 and are projected to grow at a 7.3% CAGR (2026–2035). Gamma and electron-beam systems are well suited to single-use components, selected medical devices, and high-volume applications requiring deep penetration without chemical residues.
Filtration sterilizers are expected to generate USD 0.87 billion in 2035 and expand at a 7.4% CAGR (2026–2035). Their role is strengthened by biologics and parenteral products that cannot withstand conventional heat or chemical sterilization, creating demand for validated sterile-filtration pathways.
By Application
Dairy products generated USD 2.02 billion in 2025 and are projected to represent 19.0% of the global market in 2035. The segment continues to rely on HTST and UHT systems for fluid milk, cream, and related products, with capacity additions in developing food-processing markets supporting ongoing equipment demand.
Juices & beverages are expected to generate USD 2.43 billion in 2035 after representing 16.0% of the global market in 2025. Functional beverages, plant-based drinks, tea and coffee concentrates, and fruit-based products broaden demand beyond conventional juice lines and require configurations matched to product stability and shelf-life targets.
Food processing generated USD 1.29 billion in 2025 and is projected to grow at a 5.0% CAGR (2026–2035). Export compliance, prepared-food demand, and the need for safe shelf-stable formats support investment in retort and continuous sterilization systems across sauces, ready-to-eat foods, and other processed categories.
Medical devices & surgical equipment are projected to generate USD 3.08 billion in 2035 after accounting for 18.0% of the global market in 2025. Hospital sterilization departments, device manufacturers, and contract sterilization providers are adapting to a larger installed base of complex and heat-sensitive instruments, which supports demand for both steam and low-temperature technologies.
Pharmaceuticals & biologics generated USD 1.84 billion in 2025 and are expected to account for 23.0% of the global market in 2035. The segment's importance stems from sterile injectable drugs, vaccines, complex biologics, and advanced therapies that require validated control across component preparation, formulation, filtration, and filling operations.
Water treatment is expected to generate USD 0.81 billion in 2035 after representing 5.0% of the global market in 2025. Municipal and industrial users employ ultraviolet and filtration-based systems to meet microbial-control requirements, while pharmaceutical facilities require reliable treatment for purified-water systems.
By Distribution Channel
Direct sales generated USD 5.34 billion in 2025, representing the dominant procurement channel for the pasteurizers and sterilizers market. Complex pharmaceutical and industrial food-processing projects often require direct engagement with manufacturers because buyers specify equipment against validated processes and negotiate lifecycle service requirements alongside the capital purchase. By 2035, indirect sales through distributors, system integrators, and value-added resellers are projected to generate USD 7.29 billion, expanding as mid-market food and healthcare buyers increasingly rely on channel partners for local application support, regulatory guidance, installation coordination, and aftermarket access.
GMI Analyst View
We believe the market's value center is moving toward technologies that solve material compatibility, aseptic-processing, and qualification challenges. Conventional thermal platforms remain indispensable, but suppliers with credible low-temperature, filtration, radiation, and aseptic-processing capabilities are better aligned with the demand profile of biologics and advanced medical-device applications.
Pasteurizers and Sterilizers Market Regional Analysis
North America Pasteurizers and Sterilizers Market Analysis
The North America segment of the pasteurizers and sterilizers market generated USD 2.85 billion in 2025 and is projected to account for 28.0% of global revenue in 2035. The region combines a large pharmaceutical manufacturing base, established food-processing capacity, and substantial healthcare sterilization requirements, creating durable demand for compliant equipment and technical service.
United States
The United States generated USD 2.51 billion in 2025 and is projected to represent 24.6% of the global market in 2035. Its scale reflects the concentration of drug manufacturers, biologics developers, contract manufacturers, medical-device producers, and large food and beverage processors operating under demanding safety and quality requirements.
Canada
Canada is projected to generate USD 0.54 billion in 2035 after representing 3.7% of the global market in 2025. Demand is supported by food-processing export requirements, pharmaceutical GMP investment, and healthcare facility modernization, with buyers placing value on systems supported by strong validation and service documentation.
Europe Pasteurizers and Sterilizers Market Analysis
The Europe pasteurizers and sterilizers market is projected to generate USD 4.37 billion in 2035 and accounted for 29.0% of the global market in 2025. Mature dairy, beverage, prepared-food, pharmaceutical, and healthcare sectors sustain demand, while EU GMP modernization is reinforcing equipment qualification and documentation requirements [5]European Commission. “EudraLex — Volume 4.” health.ec.europa.eu.
Germany
Germany generated USD 0.59 billion in 2025 and is projected to account for 5.9% of the global market in 2035. Its diversified pharmaceutical, biotechnology, dairy, and industrial food-processing base supports demand for high-throughput systems as well as validated sterile-manufacturing equipment.
United Kingdom
The United Kingdom is projected to generate USD 0.70 billion in 2035 after accounting for 4.7% of the global market in 2025. Biopharmaceutical production and food manufacturing create a broad equipment base, while compliance requirements for export-oriented manufacturers sustain demand for qualification, maintenance, and modernization.
France
France generated USD 0.37 billion in 2025 and is projected to represent 3.8% of the global market in 2035. Food-processing demand across dairy, specialty foods, and beverage categories is complemented by pharmaceutical sterile-manufacturing activity, creating requirements for both pasteurization and sterilization platforms.
Italy
Italy is projected to generate USD 0.52 billion in 2035 after accounting for 3.5% of the global market in 2025. Its tomato-products, dairy, preserved-food, and pharmaceutical manufacturing sectors support demand for systems that can manage product-specific processing requirements while meeting European hygiene standards.
Spain
Spain participates in the European market primarily through its food processing sector — particularly canned goods, fruit juices, olive oil, and dairy — which drives demand for batch retort sterilizers and plate pasteurizer systems operating to EU food safety standards.
Asia Pacific Pasteurizers and Sterilizers Market Analysis
The Asia Pacific pasteurizers and sterilizers market is projected to generate USD 5.18 billion in 2035 and expand at a 7.6% CAGR (2026–2035). Food-safety modernization, biologics manufacturing investment, and healthcare infrastructure development are advancing simultaneously across the region, creating a broad-based expansion in equipment demand.
China
China generated USD 0.87 billion in 2025 and is projected to represent 11.2% of the global market in 2035. Domestic pharmaceutical manufacturing, food-processing modernization, and increasingly demanding quality expectations are supporting investment in validated autoclave, radiation, and food pasteurization systems.
Japan
Japan is projected to generate USD 0.93 billion in 2035 after accounting for 4.9% of the global market in 2025. Its regulated pharmaceutical sector and quality-focused food industry support demand for high-specification equipment, maintenance services, and upgrades that improve process consistency.
India
India generated USD 0.35 billion in 2025 and is projected to account for 4.5% of the global market in 2035. Export-oriented pharmaceutical manufacturing and expanding formal food-processing capacity are advancing demand for systems that can support international GMP and food-safety requirements.
South Korea
South Korea is projected to generate USD 0.52 billion in 2035 after accounting for 2.7% of the global market in 2025. Its biopharmaceutical manufacturing ecosystem creates demand for pharmaceutical-grade sterilization infrastructure, while its beverage and food-processing industries continue to require efficient thermal processing systems.
Australia
Australia participates in the Asia Pacific market through its food export sector — particularly dairy, meat, and packaged food products requiring sterilization compliance for Asian market access — and through a growing pharmaceutical biologics manufacturing presence. Food export compliance with importing country microbial safety standards is a key driver of sterilization equipment investment among Australian food producers.
Latin America Pasteurizers and Sterilizers Market Analysis
The Latin America pasteurizers and sterilizers market generated USD 0.64 billion in 2025 and is expected to account for 7.0% of global revenue in 2035. Food and beverage processing remains the core demand base, while hospital infrastructure and pharmaceutical compliance investment provide a growing secondary source of sterilization-system demand.
Brazil
Brazil generated USD 0.34 billion in 2025 and is projected to represent 3.6% of the global market in 2035. Its large agro-industrial sector supports demand across dairy, juice, canned foods, and packaged beverages, while regulated pharmaceutical activity creates additional sterilization opportunities.
Mexico
Mexico is projected to generate USD 0.32 billion in 2035 after accounting for 2.0% of the global market in 2025. Food and beverage manufacturing for domestic consumption and North American export markets sustains pasteurizer demand, and closer pharmaceutical supply-chain integration supports investment in validated sterilization equipment.
Argentina
Argentina contributes modestly to Latin American volumes through its dairy, meat, and packaged food processing sectors, with sterilization demand shaped primarily by export compliance requirements for European and other international markets.
Middle East & Africa Pasteurizers and Sterilizers Market Analysis
The Middle East & Africa pasteurizers and sterilizers market is projected to generate USD 0.97 billion in 2035 and represented 6.0% of the global market in 2025. Growing urban populations, investments in packaged-food production, healthcare capacity expansion, and localization initiatives create long-cycle equipment demand from a comparatively lower installed base.
UAE
The UAE generated USD 0.14 billion in 2025 and is projected to account for 1.5% of the global market in 2035. Food import processing, healthcare investment, pharmaceutical logistics, and regional distribution activity support demand for equipment that can meet high hygiene and traceability expectations.
Saudi Arabia
Saudi Arabia is projected to generate USD 0.29 billion in 2035 after accounting for 1.8% of the global market in 2025. Domestic food-manufacturing development, healthcare infrastructure investment, and local pharmaceutical production initiatives are expanding the addressable market for pasteurization and sterilization systems.
South Africa
South Africa represents the largest Sub-Saharan African market for pasteurizers and sterilizers, with demand anchored in its food processing, dairy, and pharmaceutical manufacturing sectors. The country's regulatory alignment with WHO GMP guidelines for pharmaceutical manufacturing and food safety standards provides a framework for equipment investment among compliance-oriented local manufacturers.
GMI Analyst View
We view Asia Pacific as the market's principal structural growth engine because food safety, healthcare capacity, and biopharmaceutical manufacturing are expanding together. North America and Europe remain strategically important because of their installed base and demanding qualification environment, while Latin America and Middle East & Africa offer longer-cycle upside tied to financing availability and regulatory implementation.
Pasteurizers and Sterilizers Market Share & Competitive Landscape
The pasteurizers and sterilizers market share structure remains fragmented, with the top five manufacturers collectively accounting for 30.0% of the market in 2025. Competitive advantage depends on technology breadth, validation support, installed-base service capability, hygienic engineering, and the ability to address different procurement priorities in pharmaceutical, healthcare, and food-processing applications.
STERIS plc
STERIS plc held a 9.7% global market share in 2025. Its position is supported by a diversified portfolio spanning hospital sterilization equipment, life-science systems, and contract sterilization services, enabling the company to combine capital equipment exposure with recurring service activity across healthcare and pharmaceutical customer groups.
JBT Marel Corporation
JBT Marel Corporation held a 7.6% global market share in 2025. The company's combination with Marel, completed in January 2025, broadened its food-processing technology platform and strengthened its ability to serve customers requiring integrated solutions across liquid foods, beverages, protein processing, and food-safety operations [6]JBT Marel Corporation. “JBT Marel Corporation Reports JBT Standalone Fourth Quarter and Full Year 2024 Results, Provides Highlights on Marel's 2024 Results, and Establishes 2025 Guidance.” ir.jbtmarel.com. Its positioning benefits from application engineering depth and a product portfolio that addresses throughput, processing consistency, and operating efficiency.
Alfa Laval AB
Alfa Laval AB held a 5.4% global market share in 2025. The company's plate and tubular heat-transfer portfolio supports dairy, juice, and beverage processing, where energy efficiency, cleanability, and uptime are critical purchase considerations. Its Extend accessory illustrates supplier interest in reducing fouling and resource consumption within the installed base [4]Alfa Laval. “Alfa Laval Extend is sparking a sea change across the Dairy industry.” alfalaval.com.
GEA Group AG
GEA Group AG competes through a broad processing-equipment portfolio spanning dairy, beverage, food, and pharmaceutical applications. Its ability to participate in large plant projects and provide integrated engineering support is strategically important where customers are upgrading complete production lines rather than acquiring stand-alone equipment.
Getinge AB
Getinge AB maintains a focused position in hospital and life-science sterilization through steam sterilizers, washer-disinfectors, and low-temperature systems. Its product strategy addresses the growing requirement to reprocess heat-sensitive and technically complex surgical instruments while maintaining clinical workflow reliability.
Other Competitive Participants
Tetra Pak is an important participant in aseptic packaging and integrated UHT processing. Syntegon and Krones serve pharmaceutical and beverage customers, respectively, while specialists such as Feldmeier, Surdry, Steriflow SAS, Allpax, HIPERBARIC, Fedegari, CFT Group, SANOVO, and Bucher Unipektin AG address distinct processing and sterilization niches. Emerging suppliers including IBA Industrial, FTM Technologies, MicroThermics, and Claranor are developing differentiated offerings in lower-energy processing and alternative sterilization technologies.
Recent Industry Developments
JBT Marel Corporation completed its combination with Marel hf. on January 2, 2025 [6]JBT Marel Corporation. “JBT Marel Corporation Reports JBT Standalone Fourth Quarter and Full Year 2024 Results, Provides Highlights on Marel's 2024 Results, and Establishes 2025 Guidance.” ir.jbtmarel.com. The transaction expands JBT Marel's food-processing technology footprint and creates a broader platform across processing, food safety, and automation applications. The combination reflects continued industry interest in scale, technology breadth, and service reach within capital-intensive food-equipment markets.
Getinge introduced the Poladus 150 vaporized hydrogen peroxide low-temperature sterilizer in June 2024 [7]Getinge. “Getinge introduces Poladus 150 — the future of low-temperature sterilization.” getinge.com. The product targets hospital sterilization departments handling heat-sensitive surgical instruments and reflects the wider shift toward low-temperature solutions for advanced devices that may not be suitable for conventional steam processing.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →